Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
18.050USD
+0.160+0.89%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.41BMarket Cap
LossP/E TTM
More Details of Integra Lifesciences Holdings Corp Company
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Integra Lifesciences Holdings Corp Info
Ticker SymbolIART
Company nameIntegra Lifesciences Holdings Corp
IPO dateAug 16, 1995
CEOPoul (Mojdeh)
Number of employees4396
Security typeOrdinary Share
Fiscal year-endAug 16
Address1100 Campus Road
CityPRINCETON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code08540
Phone16092750500
Websitehttps://www.integralife.com/
Ticker SymbolIART
IPO dateAug 16, 1995
CEOPoul (Mojdeh)
Company Executives of Integra Lifesciences Holdings Corp
Name
Name/Position
Position
Shareholding
Change
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
FAQs
Who are the top five shareholders of Integra Lifesciences Holdings Corp?
The top five shareholders of Integra Lifesciences Holdings Corp are: Ms. Mojdeh Poul
How many institutions hold shares of Integra Lifesciences Holdings Corp (IART)?
As of 2026Q1, 574 institutions hold shares of Integra Lifesciences Holdings Corp, with a combined market value of approximately 82.80M, accounting for 106.43% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -14508057.00.
What is the biggest source of revenue for Integra Lifesciences Holdings Corp?
In 2026Q1, the Neurosurgery business generated the highest revenue for Integra Lifesciences Holdings Corp, amounting to 827.67M and accounting for 50.61% of total revenue.